Palladiem »

Arrowhead Pharmaceuticals shares owned by Palladiem

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Palladiem from 13F filings

Historical chart of Palladiem investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Palladiem consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Palladiem

Quarter filed Position value Share count Share price at filing
2025-12-31 $81k 1.2k 67.25
2020-12-31 $291k 3.8k 76.82

More positions owned by Palladiem

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Equal Weighted Etf Etf (EUSA)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Spdr Msci Eafe Strategicfactors Etf Etf (QEFA)
Spdr Gold Minishares Etv Etf (GLDM)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
St Stert Spdr Blmbg 1 3 Mn T Bl Etf Etf (BIL)
Idx Dynamic Fixed Income Etf Etf (DYFI)
Ishares Msci Intl Quality Factor Etf Etf (IQLT)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Idx Alternative Fiat Etf Etf (GLDB)
Vanguard Short-term Inflation-protected Securities Etf Etf (VTIP)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Matthews Emerging Markets Equity Active Etf Etf (MEM)
Ishares Global Materials Etf Etf (MXI)

View all positions for Palladiem

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals